Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT05566496
Recruiting Observational

The Findings of Magnetic Resonance Imaging in Subtypes of Tics-related Disorders

NCT05566496 · tracked via the Priya Life Science Taiwan tracker
Sponsor
National Taiwan University Hospital
Phase
Observational
Started
2015-10-20
Last updated
2024-08-06

Condition(s) studied

Tourette Syndrome in Children

Investigational drug(s) / intervention(s)

Brain MRI

Brain MRI: All participants receive brain MRI evaluation and clinical evaluation of tic severity.

Study summary

The findings of resting-state functional magnetic resonance imaging and diffusion spectrum imaging in subtypes of tics-related disorders

Eligibility

Sex
ALL
Min age
0 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age less than 18 years old * Diagnosed as Tourette syndrome or chronic tic disorders Exclusion Criteria: * History of neuropsychiatric disorders * Already receive treatment for Tourette syndrome/chronic tics disorder * Have some device not allowed for MRI scan

Primary outcome measure(s)

  • Difference between healthy and Tourette group — 2 years after enrollment for primary evaluation
    Difference of MRI result between healthy and Tourette group

Trial sites (1)

FacilityCityRegionStatus
National Taiwan University Children Hospital Pediatric Neurology Department Taipei Taiwan Recruiting

More National Taiwan University Hospital trials in Taiwan

Taiwan Registry for Leadless Pacemaker Enrolling by invitation
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP 2 (PALADIN2) Recruiting
Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis Recruiting
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer Recruiting
Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05566496 on ClinicalTrials.gov ↗ ← All trials in Taiwan